PET2‐driven de‐escalation therapy in 64 high‐risk Hodgkin Lymphoma patients treated with escalated BEACOPP. (9th January 2015) - Deau, Benedicte; Franchi, Patricia; Briere, Josette; Ohnona, Jessica; Tamburini, Jerome; Thieblemont, Catherine; Brice, Pauline